These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3912933)

  • 41. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prevalence of serum markers of hepatitis B virus in medical and non-medical personnel in a general hospital].
    Sánchez-Quijano A; Rivera F; Lissen E; Ollero M; Lozano F; García de Pesquera F; Vázquez R; Andreu-Kern F
    Med Clin (Barc); 1984 Jun; 83(1):1-3. PubMed ID: 6482541
    [No Abstract]   [Full Text] [Related]  

  • 43. [Superinfection with delta agent in chronic carriers of HBsAg in Spain. Clinical, epidemiologic and virologic characteristics].
    Bas L; Carreño V; Porres JC; Mora I; Gutiez J; de Torres M; Hernández Guio C
    Rev Clin Esp; 1984 Oct; 175(2):67-9. PubMed ID: 6522725
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cellular and humoral immunity in asymptomatic carriers of the hepatitis B virus].
    Asfandiiarova NS; Fazylova SM; Tkalicheva LI; Dzhavatova LS
    Ter Arkh; 1984; 56(10):47-9. PubMed ID: 6523361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kidney transplantation from hepatitis B surface antigen (HBsAg)-positive donors: changes of relative HBV genomic copy number after transplantation.
    Lai MK; Chang KS; Chueh SC; Huang CC; Chen SC; Chu SH
    Transplant Proc; 1996 Jun; 28(3):1518-9. PubMed ID: 8658767
    [No Abstract]   [Full Text] [Related]  

  • 46. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Early childhood liver cirrhosis in neonatal hepatitis B. Vertical HBV transmission through an asymptomatic HBsAg-positive mother].
    Keller KM; Helwig H; Berthold H; Uy J; Böhm N
    Med Welt; 1982 Oct; 32(40):1482-7. PubMed ID: 7202102
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hepatitis B viral markers in the liver tissue of HBs-antigen carriers].
    Mansurov KhKh; Mirodzhov GK; Tkalicheva LI
    Arkh Patol; 1984; 46(4):46-51. PubMed ID: 6375639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal gammopathies in HBsAg-positive patients with renal transplants.
    Renoult E; Bertrand F; Kessler M
    N Engl J Med; 1988 May; 318(18):1205. PubMed ID: 3283551
    [No Abstract]   [Full Text] [Related]  

  • 50. Hepatitis B surface antigen in asymptomatic carrier mothers and vertical transmission of hepatitis B virus.
    Theppisai U; Chiewsilp P; Bunyaratvej S; Siripoonya P; Varavithya W
    J Med Assoc Thai; 1984 Oct; 67 Suppl 2():90-3. PubMed ID: 6512468
    [No Abstract]   [Full Text] [Related]  

  • 51. Liver transplantation in HBsAg positive patients.
    Blumhardt G; Neuhaus P; Bechstein WO; Steffen R; Hopf U; Möller B; Raakow R; Keck H
    Transplant Proc; 1990 Aug; 22(4):1517-8. PubMed ID: 2389386
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term prognosis of HBsAg positive hepatopathy.
    Seidlová V
    Acta Univ Palacki Olomuc Fac Med; 1985; 111():287-98. PubMed ID: 2949508
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of cyclosporine on the clinical course of HBsAg-positive renal transplant patients.
    Stempel C; Lake J; Ferrell L; Tomlanovich S; Amend W; Salvatierra O; Vincenti F
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1251-2. PubMed ID: 1989202
    [No Abstract]   [Full Text] [Related]  

  • 54. Carrier status in hepatitis B: a modern scourge with hope.
    Iber FL
    JAMA; 1982 Apr; 247(16):2275-6. PubMed ID: 6279893
    [No Abstract]   [Full Text] [Related]  

  • 55. [Importance of screening tests for hepatitis B antigen and transaminase in blood service institutions for the prevention of viral hepatitis].
    Golosova TV; Burlev VA; Margolina AN; Gorzejsi I; Novák J
    Probl Gematol Pereliv Krovi; 1979 Mar; 24(3):47-8. PubMed ID: 372947
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis B surface antigenemia in renal transplant recipients. Increased mortality risk.
    Hillis WD; Hillis A; Walker WG
    JAMA; 1979 Jul; 242(4):329-32. PubMed ID: 376886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Outpatient follow-up of HBsAg-positive blood donors].
    Glasa J; Holomán J; Stancek D; Kupcová V; Jambor P; Páleníková O; Brixová E
    Bratisl Lek Listy; 1988 Mar; 89(3):220-5. PubMed ID: 3390730
    [No Abstract]   [Full Text] [Related]  

  • 58. High titres of hepatitis B surface antigen in renal transplant recipients and patients on chronic haemodialysis.
    John TJ; Shastry JC; Vijayarathnam P
    Indian J Med Res; 1979 Aug; 70():164-7. PubMed ID: 391707
    [No Abstract]   [Full Text] [Related]  

  • 59. A case report of living-related kidney transplantation between hepatitis B antigen carriers.
    Koshizuka S; Koyama I; Taguchi Y; Ogawa N; Omoto R
    Transplant Proc; 1992 Aug; 24(4):1536-7. PubMed ID: 1496650
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pathogenic mechanism of fulminant hepatic failure in HBs Ag carrier after withdrawal of cytotoxic chemotherapy].
    Inoue K; Yoshiba M; Sekiyama K; Koh I; Fujita R
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):467-72. PubMed ID: 12442428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.